Clinical Research Directory
Browse clinical research sites, groups, and studies.
Lifei Xiaoji Wan in Treatment of Advanced NSCLC
Sponsor: Henan University of Traditional Chinese Medicine
Summary
This study is to evaluate the clinical efficacy of Lifei Xiaoji Wan for advanced non-small cell lung cancer (NSCLC), establish the treatment scheme, and obtain high-quality clinical evidence.
Official title: Clinical Efficacy of Lifei Xiaoji Wan in Treatment of Advanced NSCLC
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2022-06-01
Completion Date
2024-12-31
Last Updated
2024-09-25
Healthy Volunteers
No
Conditions
Interventions
Lifei Xiaoji Wan
The Lifei Xiaoji Wan consists of ginseng, blackhead, rhubarb, aster, forehu, and thin on
Conventional treatment with Western medicine
Conventional treatment with Western medicine
Locations (1)
the First Affiliated Hospital of Henan University of Chinese Medicine
Zhengzhou, Henan, China